Clinical Trial Update: SHARE - Symbicort and Health Economics in a Real Life Evaluation [Phase 3]

View source ↗

Summary

Phase 3 SHARE trial completed evaluating Symbicort (budesonide/formoterol) with a health economics analysis in real-world asthma management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED